ER stress in adipocytes and insulin resistance: Mechanisms and significance (Review)

Molecular Medicine Reports

Volumn 10, Issue 5, 2014, Pages 2234-2240

  Khan, Shahzad ^a   Wang, Chang Hua ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Adipokines; Adipose; Er stress; Ffas; Insulin resistance

Indexed keywords

ADIPOCYTOKINE; APOPTOSIS SIGNAL REGULATING KINASE 1; C REACTIVE PROTEIN; FATTY ACID; INITIATION FACTOR 2; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; X BOX BINDING PROTEIN 1; CYTOKINE;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE TRANSPORT; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ADIPOSE TISSUE; ANIMAL; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; UNFOLDED PROTEIN RESPONSE;

ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ANIMALS; CYTOKINES; ENDOPLASMIC RETICULUM STRESS; HUMANS; INSULIN RESISTANCE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

EID: 84907189036     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2532     Document Type: Article

References (100)

1. Schröder M: Endoplasmic reticulum stress responses. Cell Mol Life Sci 65: 862-894, 2008.
2. Winnay JN and Kahn CR: PI 3-kinase regulatory subunits as regulators of the unfolded protein response. Methods Enzymol 490: 147-158, 2011.
3. van der Kallen CJ, van Greevenbroek MM, Stehouwer CD and Schalkwijk CG: Endoplasmic reticulum stress-induced apoptosis in the development of diabetes: is there a role for adipose tissue and liver? Apoptosis 14: 1424-1434, 2009.
4. Schröder M and Kaufman RJ: The mammalian unfolded protein response. Annu Rev Biochem 74: 739-789, 2005.
5. Hollien J and Weissman JS: Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science 313: 104-107, 2006.
6. Hu P, Han Z, Couvillon AD, Kaufman RJ and Exton JH: Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression. Mol Cell Biol 26: 3071-3084, 2006.
7. Urano F, Wang X, Bertolotti A, et al: Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287: 664-666, 2000.
8. Deng J, Lu PD, Zhang Y, et al: Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol Cell Biol 24: 10161-10168, 2004.
9. Jiang HY, Wek SA, McGrath BC, et al: Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. Mol Cell Biol 23: 5651-5663, 2003.
10. Wu S, Tan M, Hu Y, Wang JL, Scheuner D and Kaufman RJ: Ultraviolet light activates NFkappaB through translational inhibition of IkappaBalpha synthesis. J Biol Chem 279: 34898-34902, 2004.
11. Yamazaki H, Hiramatsu N, Hayakawa K, et al: Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response. J Immunol 183: 1480-1487, 2009.
12. Zhang K, Shen X, Wu J, et al: Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 124: 587-599, 2006.
13. Ozcan U, Cao Q, Yilmaz E, et al: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457-461, 2004.
14. Mondal AK, Das SK, Varma V, et al: Effect of endoplasmic reticulum stress on inflammation and adiponectin regulation in human adipocytes. Metab Syndr Relat Disord 10: 297-306, 2012.
15. Wu J and Kaufman RJ: From acute ER stress to physiological roles of the Unfolded Protein Response. Cell Death Differ 13: 374-384, 2006.
16. Boden G, Duan X, Homko C, et al: Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 57: 2438-2444, 2008.
17. Sharma NK, Das SK, Mondal AK, et al: Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects. J Clin Endocrinol Metab 93: 4532-4541, 2008.
18. Gregor MF, Yang L, Fabbrini E, et al: Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 58: 693-700, 2009.
19. Fleischmann E, Kurz A, Niedermayr M, et al: Tissue oxygenation in obese and non-obese patients during laparoscopy. Obes Surg 15: 813-819, 2005.
20. Virtanen KA, Lönnroth P, Parkkola R, et al: Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J Clin Endocrinol Metab 87: 3902-3910, 2002.
21. Furukawa S, Fujita T, Shimabukuro M, et al: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761, 2004.
22. Hosogai N, Fukuhara A, Oshima K, et al: Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56: 901-911, 2007.
23. Lazar MA: How obesity causes diabetes: not a tall tale. Science 307: 373-375, 2005.
24. Heilbronn LK and Campbell LV: Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des 14: 1225-1230, 2008.
25. Lewis JS, Lee JA, Underwood JC, Harris AL and Lewis CE: Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 66: 889-900, 1999.
26. Spiegelman BM: PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47: 507-514, 1998.
27. Yin J, Gao Z, He Q, Zhou D, Guo Z and Ye J: Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab 296: E333-E342, 2009.
28. Samuel VT and Shulman GI: Mechanisms for insulin resistance: common threads and missing links. Cell 148: 852-871, 2012.
29. Zeyda M and Stulnig TM: Obesity, inflammation, and insulin resistance -a mini-review. Gerontology 55: 379-386, 2009.
30. Kars M, Yang L, Gregor MF, et al: Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 59: 1899-1905, 2010.
31. Nakatani Y, Kaneto H, Kawamori D, et al: Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem 280: 847-851, 2005.
32. Ozcan U, Yilmaz E, Ozcan L, et al: Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313: 1137-1140, 2006.
33. Kim DS, Jeong SK, Kim HR, Kim DS, Chae SW and Chae HJ: Effects of triglyceride on ER stress and insulin resistance. Biochem Biophys Res Commun 363: 140-145, 2007.
34. Gual P, Le Marchand-Brustel Y and Tanti JF: Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87: 99-109, 2005.
35. Yuan M, Konstantopoulos N, Lee J, et al: Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293: 1673-1677, 2001.
36. Itani SI, Ruderman NB, Schmieder F and Boden G: Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51: 2005-2011, 2002.
37. Arkan MC, Hevener AL, Greten FR, et al: IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198, 2005.
38. Hirosumi J, Tuncman G, Chang L, et al: A central role for JNK in obesity and insulin resistance. Nature 420: 333-336, 2002.
39. Zhang K and Kaufman RJ: From endoplasmic-reticulum stress to the inflammatory response. Nature 454: 455-462, 2008.
40. Nakamura T, Furuhashi M, Li P, et al: Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 140: 338-348, 2010.
41. Kyriakis JM and Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807-869, 2001.
42. Shoelson SE, Lee J and Goldfine AB: Inflammation and insulin resistance. J Clin Invest 116: 1793-1801, 2006.
43. Boden G and Merali S: Measurement of the increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Methods Enzymol 489: 67-82, 2011.
44. Xu L, Spinas GA and Niessen M: ER stress in adipocytes inhibits insulin signaling, represses lipolysis, and alters the secretion of adipokines without inhibiting glucose transport. Horm Metab Res 42: 643-651, 2010.
45. Liu M, Zhou L, Xu A, et al: A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proc Natl Acad Sci USA 105: 18302-18307, 2008.
46. Zhou L, Liu M, Zhang J, Chen H, Dong LQ and Liu F: DsbA-L alleviates endoplasmic reticulum stress-induced adiponectin downregulation. Diabetes 59: 2809-2816, 2010.
47. Lefterova MI, Mullican SE, Tomaru T, Qatanani M, Schupp M and Lazar MA: Endoplasmic reticulum stress regulates adipocyte resistin expression. Diabetes 58: 1879-1886, 2009.
48. Hu E, Liang P and Spiegelman BM: AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703, 1996.
49. Berg AH, Combs TP and Scherer PE: ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13: 84-89, 2002.
50. Menzaghi C, Ercolino T, Di Paola R, et al: A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51: 2306-2312, 2002.
51. Kern PA, Di Gregorio GB, Lu T, Rassouli N and Ranganathan G: Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52: 1779-1785, 2003.
52. Lara-Castro C, Luo N, Wallace P, Klein RL and Garvey WT: Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55: 249-259, 2006.
53. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H and Patsch JR: Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309: 286-290, 2003.
54. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL and Murphy LJ: Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 149: 331-335, 2003.
55. Vozarova de Courten B, Degawa-Yamauchi M, Considine RV and Tataranni PA: High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 53: 1279-1284, 2004.
56. Lee JH, Chan JL, Yiannakouris N, et al: Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88: 4848-4856, 2003.
57. Gherlan I, Vladoiu S, Alexiu F, et al: Adipocytokine profile and insulin resistance in childhood obesity. Maedica (Buchar) 7: 205-213, 2012.
58. Hotamisligil GS: Inflammation and metabolic disorders. Nature 444: 860-867, 2006.
59. Friedman JM and Halaas JL: Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
60. Kiefer FW, Zeyda M, Todoric J, et al: Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology 149: 1350-1357, 2008.
61. Kahn BB and Flier JS: Obesity and insulin resistance. J Clin Invest 106: 473-481, 2000.
62. Jiao P, Ma J, Feng B, et al: FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKKβ pathways. Obesity (Silver Spring) 19: 483-491, 2011.
63. Bruun JM, Verdich C, Toubro S, Astrup A and Richelsen B: Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol 148: 535-542, 2003.
64. Sung HY, Hong CG, Suh YS, et al: Role of (-)-epigallocatechin-3-gallate in cell viability, lipogenesis, and retinol-binding protein 4 expression in adipocytes. Naunyn Schmiedebergs Arch Pharmacol 382: 303-310, 2010.
65. Meng L, Zhou J, Sasano H, Suzuki T, Zeitoun KM and Bulun SE: Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction. Cancer Res 61: 2250-2255, 2001.
66. Ruan H, Pownall HJ and Lodish HF: Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. J Biol Chem 278: 28181-28192, 2003.
67. Ritchie SA, Ewart MA, Perry CG, Connell JM and Salt IP: The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clin Sci (Lond) 107: 519-532, 2004.
68. Hotamisligil GS, Shargill NS and Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91, 1993.
69. Uysal KT, Wiesbrock SM, Marino MW and Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389: 610-614, 1997.
70. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF and Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 271: 665-668, 1996.
71. Shi H, Tzameli I, Bj?rbaek C and Flier JS: Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem 279: 34733-34740, 2004.
72. Jager J, Grémeaux T, Cormont M, Le Marchand-Brustel Y and Tanti JF: Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148: 241-251, 2007.
73. Griendling KK, Sorescu D and Ushio-Fukai M: NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
74. Xue X, Piao JH, Nakajima A, et al: Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha. J Biol Chem 280: 33917-33925, 2005.
75. Li WW, Alexandre S, Cao X and Lee AS: Transactivation of the grp78 promoter by Ca2+ depletion. A comparative analysis with A23187 and the endoplasmic reticulum Ca(2+)-ATPase inhibitor thapsigargin. J Biol Chem 268: 12003-12009, 1993.
76. Tsujino M, Hirata Y, Imai T, et al: Induction of nitric oxide synthase gene by interleukin-1 beta in cultured rat cardiocytes. Circulation 90: 375-383, 1994.
77. Cole BK, Kuhn NS, Green-Mitchell SM, et al: 12/15-Lipoxygenase signaling in the endoplasmic reticulum stress response. Am J Physiol Endocrinol Metab 302: E654-E665, 2012.
78. Zhou L and Liu F: Autophagy: roles in obesity-induced ER stress and adiponectin downregulation in adipocytes. Autophagy 6: 1196-1197, 2010.
79. Pfaffenbach KT, Gentile CL, Nivala AM, Wang D, Wei Y and Pagliassotti MJ: Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death. Am J Physiol Endocrinol Metab 298: E1027-E1035, 2010.
80. Zhou QG, Zhou M, Hou FF and Peng X: Asymmetrical dimethylarginine triggers lipolysis and inflammatory response via induction of endoplasmic reticulum stress in cultured adipocytes. Am J Physiol Endocrinol Metab 296: E869-E878, 2009.
81. Deng J, Liu S, Zou L, Xu C, Geng B and Xu G: Lipolysis response to endoplasmic reticulum stress in adipose cells. J Biol Chem 287: 6240-6249, 2012.
82. Cnop M, Foufelle F and Velloso LA: Endoplasmic reticulum stress, obesity and diabetes. Trends Mol Med 18: 59-68, 2012.
83. Boden G, Lebed B, Schatz M, Homko C and Lemieux S: Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50: 1612-1617, 2001.
84. Reaven GM, Hollenbeck C, Jeng CY, Wu MS and Chen YD: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37: 1020-1024, 1988.
85. Nguyen MT, Satoh H, Favelyukis S, et al: JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 280: 35361-35371, 2005.
86. Gao Z, Hwang D, Bataille F, et al: Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277: 48115-48121, 2002.
87. Haukeland JW, Dahl TB, Yndestad A, et al: Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol 166: 503-510, 2012.
88. Arner P: Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev 18 (Suppl 2): S5-S9, 2002.
89. Jensen MD: Adipose tissue metabolism -an aspect we should not neglect? Horm Metab Res 39: 722-725, 2007.
90. Gregor MF and Hotamisligil GS: Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res 48: 1905-1914, 2007.
91. Bollheimer LC, Skelly RH, Chester MW, McGarry JD and Rhodes CJ: Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101: 1094-1101, 1998.
92. Liu YQ, Jetton TL and Leahy JL: beta-Cell adaptation to insulin resistance. Increased pyruvate carboxylase and malate-pyruvate shuttle activity in islets of nondiabetic Zucker fatty rats. J Biol Chem 277: 39163-39168, 2002.
93. Prentki M and Nolan CJ: Islet beta cell failure in type 2 diabetes. J Clin Invest 116: 1802-1812, 2006.
94. McGarry JD and Dobbins RL: Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42: 128-138, 1999.
95. Kharroubi I, Ladrière L, Cardozo AK, Dogusan Z, Cnop M and Eizirik DL: Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145: 5087-5096, 2004.
96. Cunha DA, Hekerman P, Ladrière L, et al: Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J Cell Sci 121: 2308-2318, 2008.
97. Ryden M, Dicker A, van Harmelen V, et al: Mapping of early signaling events in tumor necrosis factor-alpha -mediated lipolysis in human fat cells. J Biol Chem 277: 1085-1091, 2002.
98. Fricke K, Heitland A and Maronde E: Cooperative activation of lipolysis by protein kinase A and protein kinase C pathways in 3T3-L1 adipocytes. Endocrinology 145: 4940-4947, 2004.
99. Kawasaki N, Asada R, Saito A, Kanemoto S and Imaizumi K: Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue. Sci Rep 2: 799, 2012.
100. Malhotra JD and Kaufman RJ: Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 9: 2277-2293, 2007.